Considering that GLP-1 analogues are not only already approved for clinical use, but may also offer additional benefits in the form of neuroprotection [30], [38], [39], they are certainly an attractive therapeutic target warranting further evaluation for their potential use in the treatment of alcohol use disorders. Here, GLP1R is linked to alcohol abuse.